CBWD inhibitors are a class of chemical compounds that specifically inhibit the activity of enzymes belonging to the CBWD (Cobalamin binding domain-containing proteins) family. These enzymes are involved in various biochemical processes, including the regulation of cobalamin (vitamin B12) metabolism, protein folding, and possibly other roles linked to cellular homeostasis. CBWD inhibitors are designed to interact with key domains of these enzymes, particularly the cobalamin-binding domain, which is crucial for their enzymatic function. By binding to the enzyme's active or allosteric sites, these inhibitors prevent the enzyme from catalyzing reactions that require the coordination of cobalamin or other substrates, effectively halting its normal activity. The ability of these inhibitors to precisely target the CBWD enzymes allows researchers to study the structural and functional aspects of these proteins in greater detail, offering insights into their roles in cellular processes.
The structural composition of CBWD inhibitors can vary widely, but they typically contain specific functional groups that interact with critical residues in the enzyme's active site or binding pocket. These interactions may include hydrogen bonding, van der Waals forces, or ionic interactions that stabilize the inhibitor within the enzyme's structure. Some inhibitors may be designed to mimic the natural substrate of the enzyme, allowing them to compete directly with cobalamin or other ligands for binding. Others may act allosterically, binding to regions of the enzyme outside the active site and inducing conformational changes that reduce its activity. The design and optimization of CBWD inhibitors often involve the use of techniques such as molecular docking, X-ray crystallography, and computational modeling to refine their specificity and potency. These inhibitors are valuable tools for probing the biological function of CBWD enzymes, providing insight into how these proteins contribute to the regulation of vitamin B12 metabolism and other critical cellular pathways.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
Ribavirin can impair the inosine monophosphate dehydrogenase, potentially affecting RNA synthesis and protein expression. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin causes premature chain termination during translation, potentially decreasing protein levels. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
This compound inhibits bacterial protein synthesis by blocking peptidyl transferase on the ribosome. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin blocks N-linked glycosylation, stressing the ER and potentially reducing overall protein levels. | ||||||
Fusidic acid | 6990-06-3 | sc-215065 | 1 g | $292.00 | ||
Fusidic acid prevents turnover of elongation factor G from the ribosome, disrupting protein synthesis. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
It inhibits inosine monophosphate dehydrogenase, leading to depleted guanine nucleotides and potentially less protein expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil is incorporated into RNA, disrupting RNA processing and function, and may reduce protein expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, leading to reduced thymidine and purine synthesis, and may suppress protein expression. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
This compound disrupts transport from the ER to the Golgi apparatus, affecting protein secretion and expression. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin, potentially altering transcriptional regulation of various genes. | ||||||